Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Aveo Pharmaceuticals (AVEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2020	12-2019	09-2019	06-2019	03-2019
Cash Flows From Operating Activities
Net Income	-8,381	9,388	13,849	-2,580	555
Depreciation Amortization	-51	-44	-1	N/A	N/A
Accounts receivable	-1,148	N/A	1,936	2,415	455
Accounts payable and accrued liabilities	1,499	-2,033	-1,316	-1,536	-1,390
Other Working Capital	-1,259	-3,611	-2,624	-2,341	-946
Other Operating Activity	-2,347	-6,619	-7,392	-10,425	-7,130
Operating Cash Flow	$-11,687	$-2,919	$4,452	$-14,467	$-8,456

Cash Flows From Investing Activities
Change In Deposits	7,848	-17,917	N/A	0	N/A
PPE Investments	-100	N/A	N/A	N/A	N/A
Investing Cash Flow	$7,748	$-17,917	$N/A	$N/A	$N/A

Cash Flows From Financing Activities
Debt Repayment	-2,389	-3,834	-1,507	N/A	N/A
Common Stock Issued	N/A	30,328	30,282	30,272	7,512
Other Financing Activity	0	-300	0	0	0
Financing Cash Flow	$-2,389	$26,194	$28,775	$30,272	$7,512

Beginning Cash Position	29,785	24,427	24,427	24,427	24,427
End Cash Position	23,457	29,785	57,654	40,232	23,483
Net Cash Flow	$-6,328	$5,358	$33,227	$15,805	$-944

Free Cash Flow
Operating Cash Flow	-11,687	-2,919	4,452	-14,467	-8,456
Capital Expenditure	-100	N/A	N/A	0	N/A
Free Cash Flow	-11,787	-2,919	4,452	-14,467	-8,456